Video

Video Report: The 2011 ASCO Annual Meeting Kicks Off in Chicago

Publish date: June 3, 2011

 

Dr. Lee Schwartzberg, editor-in-chief of Community Oncology, speaks about the highlights of this year's meeting, exciting new drugs, and the challenges oncologists face in their day-to-day practice.

Recommended Reading

In the Pipeline: Cabozantinib Shown to Control Tumors and Bone Metastases
MDedge Hematology and Oncology
Intermittent Androgen Suppression Offers Small Gains for Prostate Cancer Patients
MDedge Hematology and Oncology
Genetic Marker Predicts Taxane-Induced Neuropathy
MDedge Hematology and Oncology
Sutent Approved for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology
Low Vitamin D Associated With Poor Prognostic Features in Breast Cancer
MDedge Hematology and Oncology
Point/Counterpoint: Does Surgery Improve Survival in Stage IV Breast Cancer?
MDedge Hematology and Oncology
Abiraterone Prolongs Survival in Castration-Resistant Prostate Cancer
MDedge Hematology and Oncology
Antiviral Cidofovir May Enhance Therapies for HPV-Related Cancers
MDedge Hematology and Oncology
PIVOT Trial: No Overall Benefit to Radical Prostatectomy for Localized Prostate Cancer
MDedge Hematology and Oncology
Two Studies Find Beta-Blockers Help Combat Breast Cancer Progression
MDedge Hematology and Oncology